Alyssa Wu
Research Technician, August 2025 - Present
Alyssa is seeking to define candidate therapeutic targets in minimal residual disease in leukemia and lymphoma through the retrieval and deep molecular interrogation of rare tumor cells from patients treated on the lab’s various clinical trials. She also aims to characterize mechanisms of treatment resistance and identify biomarkers that can predict response and relapse. Outside of work, Alyssa enjoys playing the viola, reading, and pretending to understand football (Go Blue!)
